Toward a Biosignature for Suicide
Open accessAbstract
OBJECTIVE: Suicide, a major cause of death worldwide, has distinct biological underpinnings. The authors review and synthesize the research literature on biomarkers of suicide, with the aim of using the findings of these studies to develop a coherent model for the biological diathesis for suicide. METHOD: The authors examined studies covering a large range of neurobiological systems implicated in suicide. They provide succinct descriptions of each system to provide a context for interpreting the meaning of findings in suicide. RESULTS: Several lines of evidence implicate dysregulation in stress response systems, especially the hypothalamic-pituitary-adrenal axis, as a diathesis for suicide. Additional findings related to neuroinflammatory indices, glutamatergic function, and neuronal plasticity at the cellular and circuitry level may reflect downstream effects of such dysregulation. Whether serotonergic abnormalities observed in individuals who have died by suicide are independent of stress response abnormalities is an unresolved question. CONCLUSIONS: The most compelling biomarkers for suicide are linked to altered stress responses and their downstream effects, and to abnormalities in the serotonergic system. Studying these systems in parallel and in the same populations may elucidate the role of each and their interplay, possibly leading to identification of new treatment targets and biological predictors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The serotonin pathway is by far the best described pathway in depression, and several alterations in this pathway have been associated with suicidal behaviour.
“The serotonin pathway is by far the best described pathway in depression and several alterations in this pathway have been associated with suicidal behaviour.”
From Suicide and suicide risk (2019) · cites this paper as [128]
The Serotonin section says the serotonergic system has the most extensive body of research in suicide and that many studies link altered serotonin transmission to suicide risk. It does not say serotonin is the best-described pathway in depression; the claim shifts that comparison from suicide to depression. No page number is available in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 176 · Cited by 299
- Authors
- Oquendo, M. A., Sullivan, G. M., Sudol, K., Baca-Garcia, E., Stanley, B. H., Sublette, M. E., & Mann, J. J.
- Affiliations
- From the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York; the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Madrid; and the Department of Psychiatry, Fundación Jiménez Diaz Hospital and Autonomous University of Madrid.
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Venue
- American Journal of Psychiatry
- Published
- 2014-12-01
- Volume
- 171
- Issue
- 12
- Pages
- 1259-1277
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC4356635
- OpenAlex
- W2110119632
- Cited by
- 299
- References
- 176
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 20 · 2023: 24 · 2022: 28 · 2021: 35 · 2020: 29 · 2019: 26 · 2018: 43 · 2017: 28 · 2016: 28 · 2015: 10
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- National Institute of Mental Health (R01 MH48514, P50MH090964, MH48514, R01MH048514, MH090964)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- suicide, hypothalamic-pituitary-adrenal axis, stress response dysregulation, neuroinflammation, glutamatergic function, neuroplasticity, suicide risk prediction
- MeSH terms
- Brain, Dopamine, gamma-Aminobutyric Acid, Gene Expression Regulation, Humans, Hypothalamo-Hypophyseal System, Inflammation, Locus Coeruleus, Neuronal Plasticity, Norepinephrine, Pituitary-Adrenal System, Serotonin, Stress, Psychological, Suicide, Biomarkers, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review